RE:RE:RE:Financials anyone? Cash runway?
Pandora wrote: From the Ascend presentation:
- Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients. Ventripoint’s VMS product is powered by its proprietary KBR technology and provides accurate volumetric cardiac measurements with sMRI levels of accuracy. It can be used with all ultrasound systems supported by regulatory market approvals and is seamlessly integrated into the reading workflow enhancing diagnostic precision and treatment planning, ultimately improving the quality of pediatric care.
Interesting, but if they do not have cash, and they cannot close this financing how can they continue to promote and try to get any sales? This financing has been open and still could not fill and now they are going to retail investors. In the most recent financials, this is what they say, in addition to the numbers, I have posted.
There is no certainty whether the Company will generate significant revenues or attain profitable operations in the near future and there can be no assurance that it will achieve profitability in the future, as it incurred a loss of $2,608,879 and had a negative cash flow from operating activities of $1,974,232 for the six months ended June 30, 2024, and has accumulated $56,101,828 of losses as at June 30, 2024. The Company's ability to continue as a going concern is dependent on its ability to raise future capital, bringing its products to market and achieving and maintaining profitable operations. The outcome of these matters cannot be predicted at this time. As a result there exists a material uncertainty which creates significant doubt regarding the Company’s ability to continue as a going concern.